Target 1.2. Diagnostic testing guidelines
Availability of national primary diagnostic and screening testing guidelines (e.g. who to test, how to test, and when to test) is a prerequisite to guarantee sufficient sensitivity for case ascertainment and surveillance/threat notification systems.
Target 1.4. Antimicrobial drug susceptibility testing
Implementation and monitoring of compliance with EU standards for antimicrobial drug susceptibility testing is a prerequisite for accurate and comparable EU surveillance of antimicrobial resistance, in accordance with EU strategy on AMR.
EU Laboratory capacity up by 13% over the past 5 years
The new EULabCap data on microbiology system performance in the 30 EU/ EEA countries show continuous improvement.
Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey
van den Broek, I.V., Sfetcu, O., van der Sande, M.A., Andersen, , B., Herrmann, B., Ward, H., Gotz, H.M., Uuskula, A., Woodhall, S.C., Redmond, S.M., Amato-Gauci, A.J., Low, N., van Bergen, J.E.
A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe
Matei, I.A., Estrada-Peña, A., Cutler, S.J., Vayssier-Taussat, M., Varela-Castro, L., Potkonjak, A., Zeller, H., Mihalca, A.D.